Dublin, February 01, 2021 (GLOBE NEWSWIRE) – “US Pharmaceutical Test Analysis Report outlines market size, share & service analysis trends (Bioanalytical Testing, Method Development & Validation), According to End Use, and Segment Projections, 2020 Added to the report -2027 ” ResearchAndMarkets.com’s offering.
External pharmaceutical analysis test is expected to reach USD 5.55 billion market size by 2027. It is expected to expand at a CAGR of 8.3% from 2020 to 2027.
The market is largely driven by a growing number of clinical trial registrations, innovations in the medical industry, and the entry of new players in the market. In addition, an increase in R&D investment, a growing demand for biopharmaceutical products, and a growing focus on regulation, safety, and quality are some of the key factors driving market growth. .
The growing development of the pharmaceutical analytical testing services market has attracted many new players in the industry, leading to growing competition for established, unsustainable service providers. . The rapid increase in pharmaceutical manufacturing to meet the growing demand for effective healthcare in the U.S. is expected to be one of the key factors driving the demand for pharmaceutical analytics services. -outside treatment. For example, more and more preventable illness and suboptimal use of health care facilities have led to a growing demand for effective healthcare in the U.S.
The bioanalytical testing service sector is expected to see the fastest growth over the expected period. In addition, support services such as storage, logging and testing, process verification and cleaning, and resource verification are widely outsourced, and this is expected to help drive market growth. Therefore, outsourced analytical testing services provide quality results and are also a cost-effective solution.
US Highlights Pharmaceutical Test Study Market Report
- With service, the bioanalytical testing department held its second largest division in 2019 due to increased preference for external analytical testing.
- With end-use, pharmaceutical companies accounted for the largest share of 47.6% in 2019 as a result of innovative approaches to model the complexity of the tests.
- Growing demand for biopharmaceuticals, analgesic drugs, and biosimilars is expected to be one of the key contributors to market growth.
- A growing number of clinical trial registrations and the entry of new market participants over the past decade are key factors that are likely to drive the end-use segment of biopharmaceutical companies across the globe. expected time.
Key topics covered:
Chapter 1 Approach and Scope
1.1 Definition & Market scope
1.2 Research Methodology
1.3 Provision of Information
1.4 Information or Data Analysis
1.5 Market Creation & Demonstration
1.6 Model details
1.7 List of Secondary Sources
1.8 List of key sources
1.9 List of abbreviations
1.10 Amasan
Chapter 2 Executive Summary
2.1 Market outlook
Chapter 3 Market Outside US Pharmaceutical Test Study: Variations, Bias, & Scope
3.1 Segment Preview
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing innovation in probation services
3.2.1.2 Safety and quality management
3.2.1.3 Prices
3.2.2 Market Constraint Analysis
3.2.2.1 Data insecurity
3.2.2.2 Third party performance
3.3 Outlook & Growth Mapping
3.4 US External Pharmaceutical Research Review: Market analysis tools
3.4.1 Porter Five Force Analysis
3.4.2 PESTEL Analysis
Chapter 4 Outside the US Pharmaceutical Test Study Market: Service Segment Analysis
4.1 US External Pharmacy Review Study: Market Share Study, 2019 & 2027
4.2 Bioanalytical Test
4.3 Method Development & Validation
4.4 Sustainability Test
Chapter 5 Outside the US Pharmaceutical Test Study Market: End-use Segment Analysis
5.1 External US Pharmaceutical Research Study: Market Share Study, 2019 & 2027
5.2 Pharmaceutical Companies
5.3 Biopharmaceutical Companies
5.4 Contract Research Organizations
Chapter 6 Competitive Analysis
6.1 Competitive ideas
6.2 Key Markets Analysis & Strategic Alliance
Chapter 7 Company Profiles
- Western Pharmaceutical Services, Inc.
- Sgs Sa
- Scientific Eurofins
- Pace Inspection Services Llc
- Intertek Group Plc
- Pharmaceutical Product Development, LLC.
- Wuxi Apptec, Inc.
- Boston Analytical
- Charles River Laboratories International, Inc.
For more information on this report, visit https://www.researchandmarkets.com/r/50gdp3
Research and Markets also offers Custom Search services providing targeted, complete and unique search.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900